PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1955072
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1955072
The global subdural electrodes market was valued at USD 48.84 million in 2025 and is projected to grow to USD 52.87 million in 2026. The market is expected to reach USD 105.43 million by 2034, registering a CAGR of 9.00% during the forecast period (2026-2034).
The United States dominated the global market in 2025, accounting for 39.96% of the total market share, supported by a high adoption rate of intracranial monitoring procedures and a strong presence of specialized epilepsy centers.
Subdural electrodes are medical devices used for intracranial monitoring in patients suffering from epilepsy and drug-resistant seizures. These devices help locate the origin of seizures during the pre-surgical phase of epilepsy treatment, enabling surgeons to perform accurate brain mapping and improve surgical outcomes.
Market Growth Drivers
Rising Prevalence of Epilepsy
The growing global burden of epilepsy is a key driver of market expansion. According to the World Health Organization (WHO), nearly 50 million people worldwide live with epilepsy, and approximately 5 million people are diagnosed annually. Around 30% of patients fail to achieve seizure control through anti-epileptic drugs (AEDs), increasing the demand for surgical interventions and intracranial monitoring.
As epilepsy surgeries rise globally, the adoption of subdural electrodes is expected to increase significantly between 2026 and 2034.
Increasing Intracranial Monitoring Procedures
The growing number of Level 3 and Level 4 epilepsy centers is contributing to higher procedural volumes. Intracranial monitoring allows detailed visualization of seizure focus, improving procedural success rates. The superior safety, precision, and patient comfort associated with depth electrodes further support product adoption.
Market Trends
Expansion of Clinical Applications
The market is witnessing increased research into newer applications beyond epilepsy. For instance, clinical trials initiated in France explored the use of cortical electrodes in patients with head trauma and brain lesions. Such pipeline studies are expected to broaden clinical applications and drive commercialization of innovative electrode technologies.
Additionally, advancements in robot-assisted placement of depth electrodes, particularly in Japan, are supporting market growth.
Market Restraints
Lack of Awareness in Emerging Economies
Despite the high prevalence of epilepsy in low- and middle-income countries, access to advanced surgical planning remains limited. WHO data indicates that nearly 75% of people with epilepsy in low-income countries do not receive adequate treatment. Limited infrastructure, social stigma, and lack of awareness about surgical solutions restrict the adoption of subdural electrodes in emerging regions.
Market Segmentation Analysis
By Material
The market is segmented into platinum and stainless steel.
By Type
The market includes strip, grid, depth, and others.
By End-User
The market is categorized into hospitals & ASCs, specialty clinics, and others.
United States
The U.S. leads the global market, supported by strong adoption of intracranial monitoring and increasing drug-resistant epilepsy cases. The expansion of specialized epilepsy centers continues to strengthen regional dominance through 2034.
Europe
Europe is the second-leading region, driven by advanced healthcare facilities and higher adoption of depth electrodes. Approximately 18,000 craniotomies for epilepsy are performed annually in Europe, supporting steady demand.
Japan
Japan is projected to witness strong growth, supported by favorable reimbursement policies for robot-assisted electrode placement and increasing R&D initiatives.
Rest of the World
Countries such as China, India, Brazil, and South Africa are improving epilepsy surgical infrastructure, presenting future growth opportunities during the forecast period.
Key Industry Players
Major players operating in the market include:
Strategic partnerships, acquisitions, and product innovations remain key competitive strategies. For example, Natus Medical was acquired by ArchiMed in 2022, and NeuroOne received FDA clearance for its Evo sEEG Electrode.
Conclusion
The global subdural electrodes market is set to grow from USD 48.84 million in 2025 to USD 105.43 million by 2034, driven by the increasing prevalence of epilepsy, rising intracranial monitoring procedures, and technological advancements in depth electrode systems. While limited awareness in emerging markets poses challenges, expanding research initiatives and improved surgical infrastructure are expected to support sustained growth. With the U.S. maintaining leadership and Europe and Japan strengthening adoption, the market is positioned for steady expansion throughout the forecast period.
Segmentation By Material
By Type
By End-user
By Region